Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zicam Flu Relief is a homeopathic medicinal product designed for the temporary relief of symptoms associated with the influenza virus, such as fever, chills, body aches, and cough. The formulation typically includes homeopathic dilutions of *Sambucus nigra* (Elderberry), *Gelsemium sempervirens*, *Bryonia alba*, and *Sulphur*. Unlike conventional antiviral medications that target specific viral proteins like neuraminidase, Zicam Flu Relief operates under homeopathic principles, where highly diluted natural substances are intended to stimulate the body's own defense mechanisms. It is marketed as an over-the-counter (OTC) remedy and is developed by Matrixx Initiatives, a subsidiary of Church & Dwight.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zicam Flu Relief.